Detail page

Knowledge Web

Person

Dirk Heckl (1983-)

Name	Dirk Heckl
Time	1983- (Date of birth and death)
Place	Stade (Geburtsort) Hannover (Wirkungsort) Deutschland
Gender	männlich
Academic degree	Dr. rer. nat. (Med. Hochsch. Hannover) (2011)
Related	Medizinische Hochschule Hannover Klinik für Pädiatrische Hämatologie und Onkologie Biomedizin (Studienfach) Biotechnologie (Studienfach) Leukämie (Thema)
Further information	Habil. Fachgebiet Experimentelle pädiatrische Hämatologie und Onkologie, Medizinische Hochschule Hannover
Record type	Person
GND-Identifier	1015426832
Record ID	1015426832
Involved in show all Sicherheit und Wirksamkeit des Rituximab-Biosimilars Truxima® bei CD20-positiven Non-Hodgkin-Lymphomen und chronisch lymphatischer Leukämie im Rahmen der TRUDY-Registerstudie Using advanced CRISPR-Cas9 functional genetics to model and probe T cell acute lymphoblastic leukemia (T-ALL) Role of chromatin localization in respect to acute myeloid leukemia progression Combining LSD1 and JAK-STAT inhibition targets Down syndrome-associated myeloid leukemia at its core Long noncoding RNAs as regulators of pediatric acute myeloid leukemia Combining LSD1 and JAK-STAT inhibition targets Down syndrome-associated myeloid leukemia at its core Genetic barcoding systematically compares genes in del(5q) MDS and reveals a central role for CSNK1A1 in clonal expansion Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia Chromosome 21 gain is dispensable for transient myeloproliferative disorder driven by a novel GATA1 mutation Circular RNA insulin receptor protects against doxorubicin-mediated cardiotoxicity Deciphering the oncogenic network of PRC2 loss guided leukemogenesis Discovery of functional long noncoding RNA loci in acute myeloid leukemia using CRISPR/Cas9 technologies Genetic dependencies in acute myeloid leukemia revealed by a functional in vivo screening Leukämogenes Potential CRISPR-Cas9 induzierter KMT2A-Translokationen in humanen hämatopoetischen Stammzellen in vitro und in vivo Funktionelle Untersuchung onkogener Kandidaten des Chromosoms 21 in der Transienten Abnormalen Myelopoese Functional analysis of the leukemic evolution in children with Down syndrome utilizing CRISPR-Cas9 genome editing Modellierung und Untersuchung der akuten myeloischen Leukämie im Zeitalter der funktionellen Genomik Mp1 expression in normal and pathologic hematopoiesis

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Dirk Heckl (1983-)

Sicherheit und Wirksamkeit des Rituximab-Biosimilars Truxima® bei CD20-positiven Non-Hodgkin-Lymphomen und chronisch lymphatischer Leukämie im Rahmen der TRUDY-Registerstudie

Using advanced CRISPR-Cas9 functional genetics to model and probe T cell acute lymphoblastic leukemia (T-ALL)

Role of chromatin localization in respect to acute myeloid leukemia progression

Combining LSD1 and JAK-STAT inhibition targets Down syndrome-associated myeloid leukemia at its core

Long noncoding RNAs as regulators of pediatric acute myeloid leukemia

Combining LSD1 and JAK-STAT inhibition targets Down syndrome-associated myeloid leukemia at its core

Genetic barcoding systematically compares genes in del(5q) MDS and reveals a central role for CSNK1A1 in clonal expansion

Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia

Chromosome 21 gain is dispensable for transient myeloproliferative disorder driven by a novel GATA1 mutation

Circular RNA insulin receptor protects against doxorubicin-mediated cardiotoxicity

Deciphering the oncogenic network of PRC2 loss guided leukemogenesis

Discovery of functional long noncoding RNA loci in acute myeloid leukemia using CRISPR/Cas9 technologies

Genetic dependencies in acute myeloid leukemia revealed by a functional in vivo screening

Leukämogenes Potential CRISPR-Cas9 induzierter KMT2A-Translokationen in humanen hämatopoetischen Stammzellen in vitro und in vivo

Funktionelle Untersuchung onkogener Kandidaten des Chromosoms 21 in der Transienten Abnormalen Myelopoese

Functional analysis of the leukemic evolution in children with Down syndrome utilizing CRISPR-Cas9 genome editing

Modellierung und Untersuchung der akuten myeloischen Leukämie im Zeitalter der funktionellen Genomik

Mp1 expression in normal and pathologic hematopoiesis